Peter Riddell

Trichosporon inkin empyema and fungaemia following bilateral lung transplantation: diagnostic and treatment challenges.

Journal: Medical mycology case reports

Published: May 25, 2026

' 'That's just part of having a transplant, that's the price you pay " Patient-reported facilitators and barriers to immunosuppressant medication adherence among transplant recipients: a qualitative study.

Journal: Health psychology and behavioral medicine

Published: March 16, 2026

A Perspective Summary of the ISHLT Consensus Statement on Acute Lung Allograft Dysfunction (ALAD).

Journal: The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation

Published: February 23, 2026

ISHLT Consensus Statement on Acute Lung Allograft Dysfunction (ALAD): Definition, Etiology, Diagnostic and Therapeutic Approaches, and Research Priorities.

Journal: The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation

Published: February 23, 2026

Chronic lung allograft dysfunction after lung transplantation: prevention, diagnosis and treatment in 44 European centres.

Journal: ERJ open research

Published: July 09, 2024

A 2-year Review of the Diagnostic Performance of Serum and Bronchoalveolar Lavage Galactomannan Testing in Lung Transplant Recipients in a National Heart and Lung Transplant Centre.

Journal: Transplant infectious disease : an official journal of the Transplantation Society

Published: May 02, 2024

Oesophageal stasis is a risk factor for chronic lung allograft dysfunction and allograft failure in lung transplant recipients.

Journal: ERJ open research

Published: April 12, 2023

Natural killer cells, CMV infection, and antibody-mediated rejection.

Journal: The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation

Published: November 09, 2022

Donor and recipient human leukocyte antigen-G polymorphisms modulate the risk of adverse immunologic events following lung transplantation.

Journal: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons

Published: July 17, 2022

Lung transplantation for late-onset non-infectious chronic pulmonary complications of allogenic hematopoietic stem cell transplant.

Journal: Respiratory research

Published: January 29, 2021

Trichosporon inkin empyema and fungaemia following bilateral lung transplantation: diagnostic and treatment challenges.

Trichosporon inkin empyema and fungaemia following bilateral lung transplantation: diagnostic and treatment challenges.

' 'That's just part of having a transplant, that's the price you pay " Patient-reported facilitators and barriers to immunosuppressant medication adherence among transplant recipients: a qualitative study.

' 'That's just part of having a transplant, that's the price you pay " Patient-reported facilitators and barriers to immunosuppressant medication adherence among transplant recipients: a qualitative study.

A Perspective Summary of the ISHLT Consensus Statement on Acute Lung Allograft Dysfunction (ALAD).

A Perspective Summary of the ISHLT Consensus Statement on Acute Lung Allograft Dysfunction (ALAD).

ISHLT Consensus Statement on Acute Lung Allograft Dysfunction (ALAD): Definition, Etiology, Diagnostic and Therapeutic Approaches, and Research Priorities.

ISHLT Consensus Statement on Acute Lung Allograft Dysfunction (ALAD): Definition, Etiology, Diagnostic and Therapeutic Approaches, and Research Priorities.

Chronic lung allograft dysfunction after lung transplantation: prevention, diagnosis and treatment in 44 European centres.

Chronic lung allograft dysfunction after lung transplantation: prevention, diagnosis and treatment in 44 European centres.

A 2-year Review of the Diagnostic Performance of Serum and Bronchoalveolar Lavage Galactomannan Testing in Lung Transplant Recipients in a National Heart and Lung Transplant Centre.

A 2-year Review of the Diagnostic Performance of Serum and Bronchoalveolar Lavage Galactomannan Testing in Lung Transplant Recipients in a National Heart and Lung Transplant Centre.

Oesophageal stasis is a risk factor for chronic lung allograft dysfunction and allograft failure in lung transplant recipients.

Oesophageal stasis is a risk factor for chronic lung allograft dysfunction and allograft failure in lung transplant recipients.

Natural killer cells, CMV infection, and antibody-mediated rejection.

Natural killer cells, CMV infection, and antibody-mediated rejection.

Donor and recipient human leukocyte antigen-G polymorphisms modulate the risk of adverse immunologic events following lung transplantation.

Donor and recipient human leukocyte antigen-G polymorphisms modulate the risk of adverse immunologic events following lung transplantation.

A practical and immediately available size-match strategy improves short and long term outcomes in lung transplantation.

A practical and immediately available size-match strategy improves short and long term outcomes in lung transplantation.

Phenotyping CLAD after single lung transplant: Limits and prognostic assessment of the 2019 ISHLT classification system.

Phenotyping CLAD after single lung transplant: Limits and prognostic assessment of the 2019 ISHLT classification system.

Lung transplantation for late-onset non-infectious chronic pulmonary complications of allogenic hematopoietic stem cell transplant.

Lung transplantation for late-onset non-infectious chronic pulmonary complications of allogenic hematopoietic stem cell transplant.